SIGN UP
LOG IN
L
LGND
Ligand Pharma
132.72
1.14+0.87%After Hours: 132.72 0.00 0.00%16:41 08/01 EDT
OPEN/PREV CLOSE131.00/131.58
TODAY RANGE129.55-133.19
VOL155.99K
MARKET CAP2.56B
52 WEEK RANGE90.29-143.13
AVG VOL (3M)148.25K
% TURNOVER0.81%
TURNOVER--
P/E (TTM)-18.6428
% RANGE2.77%
EPS(TTM)-7.1191
P/E(FORWARD)-1,327.2000
P/B3.216
BVPS41.27
DIVIDEND--
P/S15.17
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.50B
SHARES OUTSTANDING19.29M
NEXT EARNINGS08/04-08/08
FREE FLOAT18.83M
LOT SIZE1
EX-DATE11/02/2022
News
Press Releases
Financial Reports
Profile
TipRanks·16h ago
Craig-Hallum Sticks to Its Buy Rating for Ligand Pharma (LGND)
Reuters·17h ago
BUZZ-Orchestra BioMed drops after $40 mln equity raise
TipRanks·2d ago
Ligand price target raised to $162 from $145 at Oppenheimer
Reuters·2d ago
U.S. RESEARCH ROUNDUP-Penumbra, UnitedHealth, Visa
NASDAQ·3d ago
Insiders Buy the Holdings of TECB ETF
Barchart·07/24 06:00
Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025
TipRanks·07/23 19:25
Ligand management to meet with Oppenheimer
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.